Filtered By:
Specialty: Infectious Diseases
Source: The Journal of Infection in Developing Countries
This page shows you your search results in order of date.
Order by Relevance | Date
Total 301 results found since Jan 2013.
Could ischemia-modified albumin levels predict the severity of disease in SARS-CoV-2 infection?
Conclusions: We analyzed a sample of patients with COVID-19 infection and found that IMA predicted severe COVID-19 disease. Disease severity grouping was based on patients ' clinical and radiological features. IMA level measured when SARS-CoV-2 infection is diagnosed may be a useful marker in predicting likely disease severity or intensive care need.
Source: The Journal of Infection in Developing Countries - August 30, 2023 Category: Infectious Diseases Authors: Mustafa Tanr ıverdi, Nevhiz Gündoğdu, Necla Benlier, Mustafa Yıldırım, Hale Çeliktürk, Hanifi Ayhan Özkur, Pınar Günel Karadeniz, Gülşen Özkan Tanrıverdi, Hülya Çiçek Source Type: research
Computed tomography findings in COVID-19 and atypical pneumonia: a comparative study
Conclusions: There were significant differences between the CT patterns of patients with COVID-19 and other atypical pneumonia. The presence of patchy consolidations, GGO, crazy paving patterns with typical peripheral, bilateral distribution, and absence of centrilobular nodules, pleural effusion, and multifocal consolidations may help to differentiate COVID-19 from atypical pneumonia.
Source: The Journal of Infection in Developing Countries - August 30, 2023 Category: Infectious Diseases Authors: Esra Çıvgın, İzzet Selçuk Parlak, Yasin Celal Güneş, Gülsüm Kübra Bahadır, Ayşegül Karalezli Source Type: research
Could ischemia-modified albumin levels predict the severity of disease in SARS-CoV-2 infection?
Conclusions: We analyzed a sample of patients with COVID-19 infection and found that IMA predicted severe COVID-19 disease. Disease severity grouping was based on patients ' clinical and radiological features. IMA level measured when SARS-CoV-2 infection is diagnosed may be a useful marker in predicting likely disease severity or intensive care need.
Source: The Journal of Infection in Developing Countries - August 30, 2023 Category: Infectious Diseases Authors: Mustafa Tanr ıverdi, Nevhiz Gündoğdu, Necla Benlier, Mustafa Yıldırım, Hale Çeliktürk, Hanifi Ayhan Özkur, Pınar Günel Karadeniz, Gülşen Özkan Tanrıverdi, Hülya Çiçek Source Type: research
Computed tomography findings in COVID-19 and atypical pneumonia: a comparative study
Conclusions: There were significant differences between the CT patterns of patients with COVID-19 and other atypical pneumonia. The presence of patchy consolidations, GGO, crazy paving patterns with typical peripheral, bilateral distribution, and absence of centrilobular nodules, pleural effusion, and multifocal consolidations may help to differentiate COVID-19 from atypical pneumonia.
Source: The Journal of Infection in Developing Countries - August 30, 2023 Category: Infectious Diseases Authors: Esra Çıvgın, İzzet Selçuk Parlak, Yasin Celal Güneş, Gülsüm Kübra Bahadır, Ayşegül Karalezli Source Type: research
The main predictive factors of worse outcome in patients with COVID-19 infection hospitalized in temporary COVID hospital
Conclusions: Patients with cardiovascular risk factors, low lymphocyte and platelet counts, high IL-6 and troponin T and, especially, increased age should not be treated in a TCH because of the high possibility for deterioration and need for transfer to an ICU.
Source: The Journal of Infection in Developing Countries - July 26, 2023 Category: Infectious Diseases Authors: Jovana Djurdjevic, Nina Tomonjic, Andja Cirkovic, Sretko Lukovic, Luka Pavlovic, Melanija Rasic, Marko Perovic, Ana Banko, Ivica Jeremic Source Type: research
How has the COVID-19 pandemic affected our rheumatology patients using biological/targeted DMARDs?
Conclusions: It was shown that approximately 1/5 of iRMD patients using b/tsDMARDs delayed their treatment due to the fear of COVID-19 in the first three months of the pandemic process. However, with good communication with the patients, b/tsDMARD treatment was restarted and the 12-month drug retention status was quite high.
Source: The Journal of Infection in Developing Countries - July 26, 2023 Category: Infectious Diseases Authors: Semih Gulle, Yesim Erez, Ali Karakas, Tuba Yuce Inel, Sinem Burcu Kocaer, Tuba Demirci Yildirim, Gercek Can, Ismail Sari, Merih Birlik, Fatos Onen Source Type: research
Dexamethasone, dexamethasone + remdesivir in treating moderate to severe COVID-19: retrospective observational cohort study
Conclusions: Since a similar trend was seen in both groups, our study concluded no additional role of remdesivir in combating COVID-19.
Source: The Journal of Infection in Developing Countries - July 26, 2023 Category: Infectious Diseases Authors: Nithish Sattoju, Santosh Gattu, Sai Sashank Merugu, Vydhika Anneboina, Sai Ram Ganapaka Source Type: research
Paradigm shift of respiratory viruses causing lower respiratory tract infection in children during COVID-19 pandemic in India
Conclusions: The COVID-19 pandemic significantly impacted the frequency and pattern of respiratory viruses among hospitalized children with ALRTIs in India.
Source: The Journal of Infection in Developing Countries - July 26, 2023 Category: Infectious Diseases Authors: Mannat Kang, Subhabrata Sarkar, Suresh Kumar Angurana, Pankaj Singh, Meenakshi Rana, Ishani Bora, Rishi Chetanya, Bharatendu Singh, Jayashree Muralidharan, Radha Kanta Ratho Source Type: research
The main predictive factors of worse outcome in patients with COVID-19 infection hospitalized in temporary COVID hospital
Conclusions: Patients with cardiovascular risk factors, low lymphocyte and platelet counts, high IL-6 and troponin T and, especially, increased age should not be treated in a TCH because of the high possibility for deterioration and need for transfer to an ICU.
Source: The Journal of Infection in Developing Countries - July 26, 2023 Category: Infectious Diseases Authors: Jovana Djurdjevic, Nina Tomonjic, Andja Cirkovic, Sretko Lukovic, Luka Pavlovic, Melanija Rasic, Marko Perovic, Ana Banko, Ivica Jeremic Source Type: research
How has the COVID-19 pandemic affected our rheumatology patients using biological/targeted DMARDs?
Conclusions: It was shown that approximately 1/5 of iRMD patients using b/tsDMARDs delayed their treatment due to the fear of COVID-19 in the first three months of the pandemic process. However, with good communication with the patients, b/tsDMARD treatment was restarted and the 12-month drug retention status was quite high.
Source: The Journal of Infection in Developing Countries - July 26, 2023 Category: Infectious Diseases Authors: Semih Gulle, Yesim Erez, Ali Karakas, Tuba Yuce Inel, Sinem Burcu Kocaer, Tuba Demirci Yildirim, Gercek Can, Ismail Sari, Merih Birlik, Fatos Onen Source Type: research
Dexamethasone, dexamethasone + remdesivir in treating moderate to severe COVID-19: retrospective observational cohort study
Conclusions: Since a similar trend was seen in both groups, our study concluded no additional role of remdesivir in combating COVID-19.
Source: The Journal of Infection in Developing Countries - July 26, 2023 Category: Infectious Diseases Authors: Nithish Sattoju, Santosh Gattu, Sai Sashank Merugu, Vydhika Anneboina, Sai Ram Ganapaka Source Type: research
Paradigm shift of respiratory viruses causing lower respiratory tract infection in children during COVID-19 pandemic in India
Conclusions: The COVID-19 pandemic significantly impacted the frequency and pattern of respiratory viruses among hospitalized children with ALRTIs in India.
Source: The Journal of Infection in Developing Countries - July 26, 2023 Category: Infectious Diseases Authors: Mannat Kang, Subhabrata Sarkar, Suresh Kumar Angurana, Pankaj Singh, Meenakshi Rana, Ishani Bora, Rishi Chetanya, Bharatendu Singh, Jayashree Muralidharan, Radha Kanta Ratho Source Type: research
The evaluation of the relationship between COVID-19 and autoimmune responses with a cross-sectional trial using medical records
Conclusions: The SARS-CoV-2 infection could act as a triggering factor for developing autoimmune and/or autoinflammatory dysregulation in genetically predisposed individuals.
Source: The Journal of Infection in Developing Countries - June 29, 2023 Category: Infectious Diseases Authors: Ebru Yilmaz, Salih K üçük Source Type: research
Relapse of Evans syndrome following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine: case report and literature review
Conclusions: Although it is unclear whether the relationship between COVID-19 vaccination and relapse of ES in our patient is coincidental or causal, it highlights the need for monitoring of serious outcomes following vaccination.
Source: The Journal of Infection in Developing Countries - June 29, 2023 Category: Infectious Diseases Authors: Mirjana Cvetkovi ć, Nikola Pantić, Marijana Virijević, Zlatko Pravdić, Nikica Sabljić, Mirjana Mitrović, Nada Suvajdžić-Vuković Source Type: research
Outcome of COVID-19 and tolerance of Remdesivir in patients with renal failure: a single center experience from Pakistan
Conclusions: COVID-19 in renal failure has a high risk for ICU admissions leading to increased mortality. Multiple comorbidities and raised inflammatory markers are predictors of poor outcomes. We observed no significant drug-related adverse effects, and none of our patients required discontinuation of RDV due to worsening renal function.
Source: The Journal of Infection in Developing Countries - June 29, 2023 Category: Infectious Diseases Authors: Zaheer Udin Babar, Sunil Kumar Dodani, Asma Nasim, Jawahar Lal Langhani, Sanjay Kumar Badlani Source Type: research
